Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medipharm Labs Corp
T.LABS
Alternate Symbol(s):
MEDIF
Healthcare
Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,...
packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:LABS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
...
Next
(131)
•••
QContinuum1
X
View Profile
View Bullboard History
Comment by
QContinuum1
on Mar 06, 2024 5:05pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:ANDA/NDA
How long does it normally take to make decisions at the FDA post submission? hmmmmmm
(131)
•••
QContinuum1
X
View Profile
View Bullboard History
Comment by
QContinuum1
on Mar 06, 2024 5:04pm
RE:RE:ANDA/NDA
https://www.newswire.ca/news-releases/medipharm-labs-provides-update-on-clinical-trial-progress-including-fda-approval-of-partner-study-871567881.html Beg pardon??
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Post by
subaru1i
on Mar 06, 2024 3:45pm
alleyesonme...I just put him on ignore
Got no time to look at his garbage.
(137)
•••
subaru1
X
View Profile
View Bullboard History
Comment by
subaru1
on Mar 06, 2024 3:44pm
RE:RE:ANDA/NDA
And no news since over a year ????? 20 trial and no update on any of them wow...
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Comment by
subaru1i
on Mar 06, 2024 3:44pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:ANDA/NDA
QContinuum1....you are 'out to lunch' and don't know your facts and only spreading misinformation, therefore I see no value in what you bring forth and earn the "ignore button"
...more
(137)
•••
subaru1
X
View Profile
View Bullboard History
Post by
subaru1
on Mar 06, 2024 3:42pm
Dea review, forget about March 07
When Will We Know The Outcome Of The DEA Review? Whatever the decision is, it’s not going to be reached overnight. Previous petitions having taken up to a decade to progress and the DEA is “under no
...more
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Comment by
subaru1i
on Mar 06, 2024 3:39pm
RE:ANDA/NDA
LABS indicated over a year ago....'over 20 strong clinical trials, MANY IN LATE STAGE. Read the facts buddy.
(264)
•••
alleyesonme
X
View Profile
View Bullboard History
Comment by
alleyesonme
on Mar 06, 2024 3:17pm
RE:RE:RE:RE:RE:RE:RE:RE:ANDA/NDA
If they weren't submitted they cannot claim to have clients with with such applications, they would have to be submitted to make this statement. But I understand you believe this is a blatant
...more
(131)
•••
QContinuum1
X
View Profile
View Bullboard History
Comment by
QContinuum1
on Mar 06, 2024 2:29pm
RE:RE:RE:RE:RE:RE:RE:ANDA/NDA
You don't get out much do you? I am sure LABS is working with partners that themselves are working on various FDA products; the key is just none (save the ANDA) have been submitted yet.
...more
(131)
•••
QContinuum1
X
View Profile
View Bullboard History
Comment by
QContinuum1
on Mar 06, 2024 2:26pm
RE:RE:RE:RE:RE:RE:RE:RE:ANDA/NDA
The only thing they have ever publically stated is the ANDA and just last Q call, Strachan let out that it is for Epio....that is all. They have never made any statements about other submissions and
...more
(264)
•••
alleyesonme
X
View Profile
View Bullboard History
Comment by
alleyesonme
on Mar 06, 2024 1:52pm
RE:RE:RE:RE:RE:RE:RE:ANDA/NDA
Multiple times, on conference it has been mentioned, the secrecey surrounding pharmaceutical development and its nature has clients prohibiting labs from updates until "milestones" are
...more
(264)
•••
alleyesonme
X
View Profile
View Bullboard History
Comment by
alleyesonme
on Mar 06, 2024 1:42pm
RE:RE:RE:RE:RE:RE:ANDA/NDA
Page 8 of medipharms investor deck..states "customers on every pharmaceutical commercialization path".."clinical trials..NDA..ANDA..505b2.."...this is medipharms website and
...more
(131)
•••
QContinuum1
X
View Profile
View Bullboard History
Comment by
QContinuum1
on Mar 06, 2024 1:32pm
RE:RE:RE:RE:RE:ANDA/NDA
You think because they put a check mark on an investor slide that it substiantes your position? lol Their partner has submitted an ANDA for epio, that is all because that is all we have ever
...more
(264)
•••
alleyesonme
X
View Profile
View Bullboard History
Comment by
alleyesonme
on Mar 06, 2024 1:26pm
RE:RE:RE:RE:RE:ANDA/NDA
https://assets-global.website-files.com/61b796e1c1ffa77c1c888348/6437717ea15c9aa6a342303d_2023_MediPharm-Investor-Deck-April2023%20%20Final%20Copy.pdf
Prev
...
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >